Newstral
Article
Bbarrons.com on 2020-05-06 17:27
Alexion Pharmaceuticals Beats Earnings Estimates but Cuts Guidance
Related news
- BAlexion Stock Is Rising on an Earnings Beat, Better Guidance, Buybacksbarrons.com
- Salesforce Beats Earnings Estimates For Fiscal Q4 And Raises Guidance, But Shares DropForbes
- BEli Lilly Stock Rises as Earnings Guidance Beats Analyst Expectationsbarrons.com
- BCiena Earnings Top Estimates, but Stock Slides on Guidance Cutbarrons.com
- BRegeneron Earnings Crushed Estimatesbarrons.com
- Transocean Beats Earnings Estimateswsj.com
- BAbbVie Beats Earnings Estimates as Allergan Acquisition Nearsbarrons.com
- LinkedIn Beats Earnings Estimates as More Employers Seek TalentVOX recode
- BGilead Beats Earnings Estimates, but the Stock Fallsbarrons.com
- BMacy's Beats Earnings Estimates and Raises Guidance. The Stock Jumps.1 min readbarrons.com
- BAbbott Labs Beats Earnings Expectations but Suspends Guidancebarrons.com
- CFO Moves: Alexion Pharmaceuticalsblogs.wsj.com
- BVertex Pharmaceuticals Soared on a Strong Earnings Reportbarrons.com
- BDuPont Beats Earnings Estimates but the Stock Falls. Confusing Guidance Might Be to Blame.2 min readbarrons.com
- BBristol Myers Squibb Beats Earnings Estimates, but Shares Fall2 min readbarrons.com
- BBristol Myers Squibb Beats Earnings Estimates, but Shares Fall1 min readbarrons.com
- Apple beats earnings estimates, issues healthy forecastThe Findlay Courier
- MMicron Technology beats Q3 earnings estimatesmarketwatch.com
- Lionsgate Beats Earnings Estimates, Revenues Jump 35%variety.com